Minocycline-induced cell-mediated hypersensitivity pneumonitis.

PubWeight™: 2.54‹?› | Rank: Top 2%

🔗 View Article (PMID 1503350)

Published in Ann Intern Med on September 15, 1992

Authors

J M Guillon1, P Joly, B Autran, M Denis, G Akoun, P Debré, C Mayaud

Author Affiliations

1: Hôpital Tenon, Paris, France.

Articles by these authors

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science (1997) 10.35

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85

Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20

AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (1987) 4.96

Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol (1989) 4.17

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet (1998) 3.45

Genetic control of specific immune suppression. II. H-2-linked dominant genetic control of immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT). J Exp Med (1975) 3.17

Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med (1988) 3.03

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med (1998) 2.99

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood (2001) 2.87

Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. J Exp Med (1975) 2.78

Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide. J Exp Med (1976) 2.39

Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS (1996) 2.28

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis (1988) 2.19

HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell (1994) 2.07

Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet (1999) 2.02

Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (2001) 1.97

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection. AIDS (2001) 1.90

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A (1995) 1.88

Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol (2003) 1.86

Mental navigation along memorized routes activates the hippocampus, precuneus, and insula. Neuroreport (1997) 1.86

Drugs that may injure the respiratory system. Eur Respir J (1997) 1.86

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS (1999) 1.75

Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. Eur J Immunol (1990) 1.75

Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74

A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J Immunol Methods (2003) 1.73

The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Eur J Cardiothorac Surg (2004) 1.72

The specific DNA binding activity of the dioxin receptor is modulated by the 90 kd heat shock protein. EMBO J (1990) 1.70

Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70

Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol (1998) 1.66

The stimulation of specific suppressor T cells in genetic non-responder mice by linear random copolymers of L-amino acids. Transplant Rev (1975) 1.64

Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry (2000) 1.63

CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle. Eur J Immunol (2000) 1.62

Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn (1995) 1.59

FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci (1999) 1.58

Genetic control of specific immune suppression. III. Mapping of H-2 complex complementing genes controlling immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT). J Exp Med (1976) 1.57

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55

Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52

Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Is the prognosis really improved? Chest (1993) 1.51

Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS (1999) 1.47

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol (1997) 1.46

[Epidemiology and diagnosis of respiratory syncitial virus in adults]. Rev Mal Respir (2004) 1.45

[Complication of radical lymph node dissection following sentinel lymph node biopsy in patients with melanoma]. Ann Dermatol Venereol (2013) 1.44

Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J Immunol (1996) 1.43

Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest (1992) 1.43

T lymphocyte subsets in primary antiphospholipid syndrome. J Rheumatol (1994) 1.43

CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. Lancet (1992) 1.42

Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol (2001) 1.42

Human immunodeficiency virus-related lymphocytic alveolitis. Chest (1988) 1.40

Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups. J Immunol (2000) 1.39

Increased prevalence of psoriasis in patients with coronary artery disease: results from a case-control study. Br J Dermatol (2014) 1.39

Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir Cell Mol Biol (1993) 1.38

[Contact vasculitis caused by topical agents with non-steroidal anti-inflammatory agents or analgesics]. Ann Dermatol Venereol (1997) 1.38

Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS (1988) 1.37

Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood (1999) 1.36

Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol (1989) 1.33

Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol (1995) 1.32

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol (2009) 1.32

Usefulness of PCR for detection of Pneumocystis carinii DNA. J Clin Microbiol (1994) 1.30

Specific protein-DNA interactions at a xenobiotic-responsive element: copurification of dioxin receptor and DNA-binding activity. Proc Natl Acad Sci U S A (1989) 1.29

Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol (2001) 1.28

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol (2013) 1.27

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27

Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26

Neural correlates of topographic mental exploration: the impact of route versus survey perspective learning. Neuroimage (2000) 1.26

Human neutrophils, activated with cytokines or not, do not kill virulent Mycobacterium tuberculosis. J Infect Dis (1991) 1.26

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure. AIDS (2001) 1.24

Comparison of minus power anterior chamber intraocular lenses and myopic epikeratoplasty in phakic eyes. Refract Corneal Surg (1991) 1.23

NF-kappa B activation by tumor necrosis factor alpha in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca(2+)-regulated kinases. Cytokine (1991) 1.23

Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol (1996) 1.23

CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood (1992) 1.23

Association of major aphthous ulcers and nicorandil. Lancet (1998) 1.22

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22

Acquired immunodeficiency syndrome in France. Lancet (1983) 1.21

Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol (1987) 1.20

Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood (2001) 1.20

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. J Virol (2001) 1.20

Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis (1995) 1.20

Control of the Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria. Clin Exp Immunol (1986) 1.19